Healthcare provider profile · identity verified

Mark R Roberts, DO

Internal Medicine · STILLWATER, MN · NPI 1386740843

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	849	248
Lisinopril	Lisinopril	536	151
Amlodipine Besylate	Amlodipine Besylate	514	162
Levothyroxine Sodium	Levothyroxine Sodium	434	115
Omeprazole	Omeprazole	426	141
Losartan Potassium	Losartan Potassium	412	126
Metoprolol Succinate	Metoprolol Succinate	407	125
Simvastatin	Simvastatin	310	84
Hydrochlorothiazide	Hydrochlorothiazide	303	82
Gabapentin	Gabapentin	279	81
Pantoprazole Sodium	Pantoprazole Sodium	263	80
Tamsulosin Hcl	Tamsulosin Hcl	246	77
Rosuvastatin Calcium	Rosuvastatin Calcium	231	78
Prednisone	Prednisone	214	108
Metformin Hcl Er	Metformin Hcl	206	64
Furosemide	Furosemide	201	70
Trazodone Hcl	Trazodone Hcl	197	64
Citalopram Hbr	Citalopram Hydrobromide	177	55
Warfarin Sodium	Warfarin Sodium	165	44
Atenolol	Atenolol	153	44
Albuterol Sulfate Hfa	Albuterol Sulfate	145	64
Xarelto	Rivaroxaban	143	28
Allopurinol	Allopurinol	141	43
Eliquis	Apixaban	137	35
Metformin Hcl	Metformin Hcl	136	36
Lorazepam	Lorazepam	129	33
Ozempic	Semaglutide	127	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	36
Azithromycin	Azithromycin	115	53
Sertraline Hcl	Sertraline Hcl	99	29
Fluoxetine Hcl	Fluoxetine Hcl	96	27
Metoprolol Tartrate	Metoprolol Tartrate	96	32
Oxycodone Hcl	Oxycodone Hcl	96	24
Tramadol Hcl	Tramadol Hcl	95	26
Carvedilol	Carvedilol	94	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	91	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	90	23
Fluticasone Propionate	Fluticasone Propionate	87	37
Glimepiride	Glimepiride	84	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	28
Pravastatin Sodium	Pravastatin Sodium	80	25
Duloxetine Hcl	Duloxetine Hcl	78	15
Jardiance	Empagliflozin	74	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	74	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	72	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	19
Bupropion Xl	Bupropion Hcl	66	21
Clopidogrel	Clopidogrel Bisulfate	66	23
Alprazolam	Alprazolam	64	17
Finasteride	Finasteride	64	21
Trulicity	Dulaglutide	64	11
Montelukast Sodium	Montelukast Sodium	61	17
Alendronate Sodium	Alendronate Sodium	59	17
Ezetimibe	Ezetimibe	59	23
Potassium Chloride	Potassium Chloride	59	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	26
Spironolactone	Spironolactone	58	19
Clonazepam	Clonazepam	57	13
Escitalopram Oxalate	Escitalopram Oxalate	54	18
Famotidine	Famotidine	54	21
Glipizide Er	Glipizide	54	19
Meloxicam	Meloxicam	53	19
Pregabalin	Pregabalin	52	16
Triamcinolone Acetonide	Triamcinolone Acetonide	46	29
Paroxetine Hcl	Paroxetine Hcl	42	12
Cephalexin	Cephalexin	41	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	11
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	11
Mirtazapine	Mirtazapine	37	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	12
Donepezil Hcl	Donepezil Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	11
Lovastatin	Lovastatin	29	suppressed
Nitroglycerin	Nitroglycerin	29	18
Zolpidem Tartrate Er	Zolpidem Tartrate	29	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Amoxicillin	Amoxicillin	26	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	20
Doxycycline Monohydrate	Doxycycline Monohydrate	25	17
Ipratropium Bromide	Ipratropium Bromide	25	11
Irbesartan	Irbesartan	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Baclofen	Baclofen	23	suppressed
Flecainide Acetate	Flecainide Acetate	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Ondansetron Odt	Ondansetron	23	12
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Methadone Hcl	Methadone Hcl	22	suppressed
Diazepam	Diazepam	21	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Clonidine	Clonidine	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Methylprednisolone	Methylprednisolone	17	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Victoza 3-Pak	Liraglutide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Cardizem Cd	Diltiazem Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error